Research reveals SLC13A3’s role in tumor cell survival and immune therapy resistance, highlighting its potential as a target for improved cancer treatments.
Key reason why some cancers do not respond to immunotherapy identified
- Post author:
- Post published:November 12, 2024
- Post category:uncategorized
- Post comments:0 Comments